マイクロスケール熱泳動によって結合親和性の決定のタンパク質精製·フリー法

Executive Industry Relevance

Determining binding affinity directly from cell lysates eliminates the bottleneck of protein purification, accelerating early-stage target validation and lead identification. This approach enables rapid assessment of protein-ligand interactions in a near-physiological context, improving predictive confidence for downstream screening campaigns. By reducing time and resource investment in protein production, the method supports higher-throughput screening of difficult targets such as transcription factors and membrane proteins.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses by measuring binding affinities of GFP-tagged proteins to oligonucleotides, peptides, or small molecules directly from lysates.
• Operational Value: Avoids protein purification steps, reducing timelines and costs associated with expressing and isolating difficult targets like STAT3.
• Predictive Value: Provides quantitative KD measurements that support target prioritization and go/no-go decisions in early discovery.

Screening & Assay Development

• Assay Readiness: Generates reproducible, quantitative binding data from lysate-based systems suitable for hit confirmation and SAR exploration.
• Scalability: Compatible with serial ligand dilution formats and capillary-based MST platforms, enabling medium-throughput affinity profiling.
• Contextual Relevance: Maintains physiological buffer conditions and tolerates detergents, preserving native protein states for more translatable interaction data.

Translational & Preclinical Research

• Translational Continuity: Supports mechanistic de-risking by validating target engagement in lysate systems that reflect cellular complexity.
• Biomarker Alignment: Enables assessment of how mutations or post-translational modifications affect binding, informing structure-function relationships relevant to disease variants.
• Risk-Adjusted Advancement: Affinity data from native-like environments improves confidence in selecting leads with favorable target interaction profiles.

Pipeline & Workflow Integration

The method fits within the discovery continuum from target validation through lead identification, offering a lysate-compatible alternative to purified-protein assays for affinity measurement.

• Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying binding of GFP-fused transcription factors to DNA or protein ligands without purification.
• Screening: Enables assay readiness through standardized lysate preparation and ligand titration, yielding reproducible MST thermophoresis curves for affinity ranking.
• Analytics: Generates KD values with standard deviations from averaged MST thermophoresis traces, providing statistical outputs for comparing ligand potency and selectivity.
• Translational Research: Connects early binding data to preclinical relevance by using lysates from disease-relevant cell models (e.g., HEK293 expressing STAT3-GFP) to assess target behavior in near-native conditions.
• Enterprise Reuse: Establishes a reusable lysate-based MST workflow applicable across multiple targets and ligand classes, reducing dependency on protein purification bottlenecks.

Operational & Enterprise Impact

• Scientific Value: Delivers predictive confidence through quantitative affinity measurements that reduce mechanistic ambiguity in target-ligand interactions.
• Operational Value: Increases standardization and reproducibility by eliminating variability introduced during protein purification and enabling direct comparison across lysate preparations.
• Strategic Value: Improves capital efficiency by accelerating hit validation and reducing late-stage attrition due to poor target engagement predictions.
• Portfolio Impact: Enables risk-adjusted prioritization of targets based on lysate-derived affinity data, supporting better resource allocation in early discovery portfolios.

Implementation Considerations

• Requires expertise in fluorescent protein tagging, cell culture, and lysate preparation under non-denaturing conditions.
• Dependent on access to an MST instrument with appropriate LED excitation (e.g., 470 nm for GFP) and capillary loading capabilities.
• Necessitates standardization of lysate dilution and ligand titration protocols to maintain fluorescence within the optimal 400–1500 unit range.
• Requires optimization for different protein classes (e.g., membrane proteins may need detergent-containing buffers) and ligand solubility considerations.
• Limited by the need for detectable fluorescence changes upon binding; may require validation for ligands that induce minimal thermophoresis shifts.

Biopharma FAQs